- Home
- NOTV vs SANG Comparison
NOTV vs SANG Comparison
Compare NOTV & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- SANG
- Stock Information
- Founded
- NOTV 1974
- SANG 1984
- Country
- NOTV United States
- SANG Canada
- Employees
- NOTV N/A
- SANG N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- NOTV Health Care
- SANG Technology
- Exchange
- NOTV Nasdaq
- SANG Nasdaq
- Market Cap
- NOTV 137.5M
- SANG 153.5M
- IPO Year
- NOTV 1997
- SANG 2021
- Fundamental
- Price
- NOTV $1.64
- SANG $4.77
- Analyst Decision
- NOTV Strong Buy
- SANG
- Analyst Count
- NOTV 3
- SANG 0
- Target Price
- NOTV $5.92
- SANG N/A
- AVG Volume (30 Days)
- NOTV 1.2M
- SANG 6.2K
- Earning Date
- NOTV 05-09-2025
- SANG 05-07-2025
- Dividend Yield
- NOTV N/A
- SANG N/A
- EPS Growth
- NOTV N/A
- SANG N/A
- EPS
- NOTV N/A
- SANG N/A
- Revenue
- NOTV $475,114,000.00
- SANG $241,243,000.00
- Revenue This Year
- NOTV $6.07
- SANG N/A
- Revenue Next Year
- NOTV $5.74
- SANG $3.21
- P/E Ratio
- NOTV N/A
- SANG N/A
- Revenue Growth
- NOTV N/A
- SANG N/A
- 52 Week Low
- NOTV $1.15
- SANG $4.04
- 52 Week High
- NOTV $6.48
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- NOTV 38.13
- SANG 51.88
- Support Level
- NOTV $1.15
- SANG $4.55
- Resistance Level
- NOTV $1.85
- SANG $4.76
- Average True Range (ATR)
- NOTV 0.44
- SANG 0.20
- MACD
- NOTV -0.05
- SANG 0.10
- Stochastic Oscillator
- NOTV 28.16
- SANG 89.61
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.